1. Home
  2. List
Reference Patent

Reference - List

  • 85 Hits
  • Search Condition : Filter (MeSH = Drug Resistance, Neoplasm / genetics)
Species Resource Title
Human and Animal Cells CW-2(RCB0778) Co-targeting KRASG12D and the HER family is efficacious in colorectal cancer.
Human and Animal Cells Ba/F3 Targeting EGFR-Mcl-1 Axis by Piperlongumine as a Novel Strategy for Non-Small Cell Lung Cancer Therapy.
Human and Animal Cells HeLa Establishment of KGAS, a cell line derived from gastric-type adenocarcinoma of the uterine cervix.
Human and Animal Cells Ba/F3(RCB0805) Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation.
Human and Animal Cells Ba/F3(RCB4476) Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations-An In Vitro Study.
DNA material mCherry-hCdt1(30/120)/ pCSII-EF (RDB15273) , mVenus-hGeminin(1/110) / pCSII-EF (RDB15271) CREBBP inactivation sensitizes B cell acute lymphoblastic leukemia to ferroptotic cell death upon BCL2 inhibition.
Human and Animal Cells PK-45H(RCB1973) Exosomal miR-199a-3p Secreted From Cancer-Associated Adipocytes Promotes Pancreatic Cancer Progression.
DNA material CS-RfA-EG (RDB04391) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells.
DNA material CSII-CMV-MCS-IRES2-Bsd (RDB04385) Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer.
Human and Animal Cells Ba/F3-CL1(RCB4474) Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion.
Human and Animal Cells A431(RCB0202) Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib.
Human and Animal Cells SSP-25(RCB1293) Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation.
Human and Animal Cells HGC-27(RCB0500) Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells.
Human and Animal Cells OVK18(RCB1903) Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin.
Human and Animal Cells Ba/F3(RCB0805) Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer.
Human and Animal Cells Rat-1(RCB1830) Synergistic effect of combined PI3 kinase inhibitor and PARP inhibitor treatment on BCR/ABL1-positive acute lymphoblastic leukemia cells.
Human and Animal Cells Lu99(RCB1900) , LU65(RCB1967) PAK and PI3K pathway activation confers resistance to KRASG12C inhibitor sotorasib.
Human and Animal Cells JHOS-2(RCB1521) , JHOS-4(RCB1678) Circular RNA circPBX3 promotes cisplatin resistance of ovarian cancer cells via interacting with IGF2BP2 to stabilize ATP7A mRNA expression.
Human and Animal Cells Ba/F3(RCB0805) , WEHI-3(RCB0035) Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation.
Human and Animal Cells 8505C(RCB2103) , HTC/C3(RCB0452) , HOTHC(RCB0662) BRAF Inhibitors Induce Feedback Activation of RAS Pathway in Thyroid Cancer Cells.